Tasso and UBC Announce Partnership
At-home blood sample collection and analysis solutions for post-approval research through joint offering.
Tasso, Inc., United BioSource LLC (UBC) have partnered to bring Tasso’s devices for at-home, clinical-grade blood sample collection and end-to-end collection and analysis solutions with UBC’s late-stage research expertise in evidence development and participant support services.
Research utilizing the joint offering will be powered by Tasso’s integrated solutions to streamline blood sample collection and analysis. After sponsors provide a list of samples needed, Tasso will handle shipping at-home blood collection kits directly to research participants, manage transport of samples to an analytical laboratory that has validated the specific test(s) needed, and communicate lab results back to the sponsor. The fully integrated Tasso Connect portal will ensure samples can be tracked with out-of-the-box functionality, and for seamless connectivity, partners can link with their own systems through Tasso’s API integration.
Tasso and UBC have recently been awarded a late-stage biomarker monitoring study.
Reference: Tasso and UBC Partner to Advance Decentralized Sample Collection and Analysis Solutions for Post-Approval Research. Seattle and Blue Bell, PA, June 27, 2023.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025